Pharmacists’ Perceptions of the Benefits and Challenges of Electronic Product Information System Implementation in Hong Kong: Mixed-Method Study

Author:

Fung Eunice Wing ToORCID,Au-Yeung Gordon Tsz FungORCID,Tsoi Lo MeiORCID,Qu LiliORCID,Cheng Tommy Kwan WaORCID,Chong Donald Wing-KitORCID,Lam Teddy Tai NingORCID,Cheung Yin TingORCID

Abstract

Background With the advancement of technology, more countries are now adopting the use of electronic product information (ePI), which refer to an electronic version of physical product inserts in a semistructured format optimized for electronic manipulation. The successful implementation of ePI has led to advantages and convenience to patients, health care professionals, and pharmaceutical companies in many regions and countries. In the Hong Kong Special Administrative Region (SAR), there is currently no citywide implementation of ePI. The SAR exhibits conditions that would favor the implementation of an ePI system, as well as existing barriers hindering its implementation. However, no study has been performed to examine the specific situation in Hong Kong. Objective The objective of this study is to explore working pharmacists’ overall perception of ePI and to identify potential challenges to the implementation of an ePI system in Hong Kong. Methods This mixed-method study involved a structured survey and interview with practicing pharmacists in Hong Kong. Pharmacists were eligible if they were licensed to practice in Hong Kong, and currently working locally in any pharmacy-related sectors and institutions. Respondents completed a survey to indicate their level of agreement with statements regarding the potential advantages of ePI over paper PI. A structured interview was conducted to gather respondents’ perceived advantages of ePI over paper PI in different aspects, such as professionalism, usability, presentation, and environment, as well as challenges of citywide ePI implementation in Hong Kong. Thematic analysis was adopted to analyze the qualitative data. Grounded theory was used to generate themes and identify specific outcomes. Results A total of 16 pharmacists were recruited, comprising 4 community pharmacists, 5 hospital pharmacists, and 7 industrial pharmacists. All of them used electronic platforms at least once per month on average. Respondents identified many flaws in physical package inserts that can potentially be mitigated using ePI. The speed with which drug information can be retrieved and the degree to which the drug information can be readily updated and disseminated were considered the greatest strengths of ePI. The clarity with which ePI present drug information to patients was considered as the weakest aspect of ePI. Many respondents highlighted concerns about the security risks and high cost associated with system maintenance and that certain subpopulations may not be sufficiently computer literate to navigate the ePI system. Respondents also voiced many concerns about the implementation and maintenance of a local ePI system. Conclusions We conclude that an ePI system is generally supported by pharmacists but concerns about implementation process and maintenance of the system has been raised. The perceived benefits of ePI gathered from this study, as well as collective evidence from other countries with mature ePI systems, confirm that more efforts should be made to promote optimized development and implementation of an ePI system in Hong Kong.

Publisher

JMIR Publications Inc.

Subject

Health Informatics

Reference30 articles.

1. KnightNMorelandJDigitising product information: Greater accessibility for public health & all patients2020-05-11https://www.ema.europa.eu/en/documents/presentation/presentation-digitising-product-information-greater-accessibility-public-health-all-patients-n_en.pdf

2. European Medicines AgencyHeads of Medicines AgenciesEuropean CommissionElectronic product information for medicines in the EU: Report from an EMA–HMA–EC workshop held on 28 November 201820192020-05-11https://www.ema.europa.eu/en/documents/report/report-european-medicines-agency-ema/heads-medicines-agencies-hma/european-commission-ec-workshop-electronic-product-information-epi_en.pdf

3. United States National Library of MedicineDailyMed20202020-06-17https://dailymed.nlm.nih.gov/dailymed/index.cfm

4. Australian Government Department of HealthTherapeutic Good Administration. 2020. Product Information2020-06-17https://www.tga.gov.au/product-information-0

5. Pharmaceuticals and Medical Devices Agency (PMDA) - JapanSafety Alert & Recalls/Review Reports/Package Inserts2020-06-17https://www.pmda.go.jp/english/search_index.html

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3